SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA Press.
  • Antar LN, Afroz R, Dictenberg JB, Carrol RC, Bassel GJ. 2004. Metabotropic glutamate receptor activation regulates Fragile X mental retardation protein and Fmr1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24: 26482655.
  • Araghi-Niknam M, Fatemi SH. 2003. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol 6: 945952.
  • Aronica E, van Vliet EA, Mayboroda OA, Troost D, da Silva FH, Groter JA. 2000. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 12: 23332344.
  • Bailey DB, Hatton DD, Mesibov GB, Ament N, Skinner M. 2000. Early development, temperament, and functional impairment in autism and fragile X syndrome. J Autism Dev Disord 30: 557567.
  • Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of Fragile X mental retardation. Trends Neurosci 27: 370377.
  • Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. 2009. A pilot open label, single dose of fenobam in adults with Fragile X syndrome. J Med Genet 46: 266271.
  • Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT. 2008. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 29: 293302.
  • Blatt GJ. 2005. GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int Rev Neurobiol 71: 167178.
  • Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. 2001. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Aut Dev Disord 31: 537544.
  • Breese CR, Freedman R, Leonard SS. 1995. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674: 8290.
  • Bureau M, Olsen RW. 1990. Multiple distinct subunits of the γ-aminobutyric acid-A receptor protein show different ligand-binding affinities. Mol Pharmacol 37: 497502.
  • Catania MV, D'Antoni S, Bonaccorso CM, Aronica E, Bear MF, Nicoletti F. 2007. Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? Mol Neurobiol 35: 298307.
  • Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, Bagni C. 2008. Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. 63: 963973.
  • Cohen I. 1995. Behavioral profiles of autistic and nonautistic fragile X males. Dev Brain Dyn 8: 252269.
  • Copani A, Casabona G, Bruno V, Caruso A, Condorelli DF, Messina A, Di Giorgi-Gerevini V, Pin J-P, Kuhn R, Knöpfel T, Nicoletti F. 1998. The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons. Eur J Neurosci 10: 21732184.
  • Copani A, Romano C, Di Giorgi Gerevini V, Nicosia A, Casabona G, Storto M, Mutel V, Nicoletti F. 2000. Reducing conditions differentially affect the functional and structural properties of group-I and -II metabotropic glutamate receptors. Brain Res 867: 156172.
  • Crawford DC, Meadows KL, Newman JL, Taft LF, Pettay DL, Gold LB, Hersey SJ, Hinkle EF, Stanfield ML, Holmgreen P, Yeargin-Allsopp M, Boyle C, Sherman SL, 1999. Prevalence and phenotype consequence of FRAXA and FRAXE allele in a large ethnically diverse, special education-needs population. Am J Hum Genet 64: 495507.
  • Darnell JC, Fraser CE, Mostovetsky O, Darnell RB. 2009. Discrimination of common and unique RNA-binding activities of Fragile X mental retardation protein paralogs. Hum Mol Genet 18: 31643177.
  • D'Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn PP, Hassan BA, Kooy RF. 2006. Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121: 238245.
  • DeLorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD. 2008. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia or cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res 187: 207220.
  • De Rubeis S and Bagni C. 2010. Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability. Mol Cell Neurosci 43: 4350.
  • Dölen G, Bear MF. 2008. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of Fragile X syndrome. J Physiol 586: 15031508.
  • Dölen G, Osterweil E, Shankaranarayana Rao BS, Smith GB, Auerbach D, Chattarji S, Bear MF. 2007. Correction of fragile X syndrome in mice. Neuron 56: 955962.
  • El Idrissi A, Ding XH, Scalia J, Trenkner E, Brown WT, Dobkin C. 2005. Decreased GABAA receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377: 141146.
  • Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. 2009b. Expression of GABA(B) receptors is altered in brains of Subjects with autism. Cerebellum 8: 6469.
  • Fatemi SH, Halt AR. 2001. Altered levels of Bcl-2 and P53 proteins in parietal cortex reflect decreased apoptotic regulation in autism. Synapse 42: 281284.
  • Fatemi SH, Halt A, Stary J, Kanodia R, Schulz SC, Realmuto G. 2002a. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in parietal and cerebellar cortices of autistic subjects. Biol Psychiatry 52: 805810.
  • Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. 2009a. GABA(A) Receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39: 223230.
  • Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras PD. 2010. mRNA and Protein Levels for GABA(A) alpha 4, alpha 5, beta 1, and GABA(B)R1 Receptors are Altered in Brains from Subjects with Autism. J Autism Dev Disord 40: 743750.
  • Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce D, 2005. Reelin signaling is impaired in autism. Biol Psychiatry 57: 777787.
  • Fatemi SH, Stary J, Egan EA. 2002b. Reduced blood levels of Reelin as a vulnerability factor in the pathophysiology of autistic disorder. Cel Mol Neurosci 22: 139152.
  • Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersh SM. 1997. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17: 15391547.
  • Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J. 2001. Activated astrocytes in areas of kainite-induced neuronal injury upregulate the expression of metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 137: 111.
  • Fombonne E. 2006. Past and future perspectives on autism epidemiology. In: Moldin SO, Rubenstein JLR, editors. Understanding autism from basic neuroscience to treatment. Boca Raton, FL: CRC/Taylor and Francis. p 2548.
  • Gantois I, Vandescompele J, Speleman F, Reyniers E, D'Hooge R, Severijnen LA, Willemsen R, Tassone F, Kooy RF. 2006. Expression profiling suggests underexpression of the GABAA receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 21: 346357.
  • Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM. 2008. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30: 303311.
  • Gothelf, D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R, Erba HW, Ringel J, Hayashi KM, Patnaik S, Golianu B, Kraemer HC, Thompson PM, Piven J, Reiss AL. 2008. Neuroanatomy of Fragile X syndrome is associated with aberrant behavior and the Fragile X mental retardation protein (FMRP). Ann Neurol 63: 4051.
  • Goudet C, Kniazeff J, Hlavackova V, Malhaire F, Maurel D, Acher F, Blahos J, Prézeau L, Pin J-P. 2005. Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem 280: 2438024385.
  • Grossman AW, Aldridge GM, Weiler IJ, Greenough WT. 2006. Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci 26: 71517155.
  • Hatton DD, Sideris J, Skinner M, Mankowski J, Bailey DB,Jr., Roberts J, Mirrett P. 2006. Autistic behavior in children with Fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet A 140A: 18041813.
  • Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S. 2007. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104: 1148911494.
  • Hermans E, Challiss RAJ. 2001. Structural, signaling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J 359: 465484.
  • Irwin SA, Christmon CA, Grossman AW, Galvez R, Kim SH, DeGrush BJ, Weiler IJ, Greenough WT. 2005. Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis. Neurobiol Learn Mem 83: 180187.
  • Kanner L. 1943. Autistic disturbances of affective contact. J Nerv Child 2: 217250.
  • Kauffman WE, Cortell R, Kau A, bukelis I, Tierney E, Gray R, Cox C, Capone G, Stanard P. 2004. Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors. Am J Med Genet Part A 129A: 225234.
  • Keene JD. 2007. RNA regulons: coordination of post-translational events. Nat Rev Genet 8: 533543.
  • Knöpfel T, Grandes P. 2002. Metabotropic glutamate receptors in the cerebellum with a focus on their function in Purkinje cells. Cerebellum 1: 1926.
  • Laurence JA, Fatemi SH. 2005. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4: 206210.
  • Lecourtier L, Homayoun H, Tamagnan G, Moghaddam B. 2007. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol Psychiatry 62: 739746.
  • López-Bendito G, Shigemoto R, Farién A, Luján R. 2002. Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12: 625638.
  • Lu R, Wang H, Liang Z, Ku L, O'Donnell WT, Li W, Warren ST, Feng Y. 2004. The Fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci USA 101: 1437414378.
  • Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder JC. 1997. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17: 51965205.
  • Melik-Musyan AB, Fanardzhyan W. 2004. Morphological characteristics of Lugaro cells in the cerebellar cortex. Neurosci Behav Physiol 34: 633638.
  • Mienville, JM. 1999. Cajal-Retzius cells physiology: just in time to bridge the 20th century. Cereb Cortex 9: 776782.
  • Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Dalla Bernardina B, Tassinari CA, De Sarro GB, Elia M. 1999. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40: 10921099.
  • Naur P, Vestergaard B, Dkov LK, Egebjerg J, Gajhede M, Kastrup JS. 2005. Crystal structure of the kainite receptor GluR5 ligand-binding core in complex with (S)-glutamate. FEBS Lett 579: 11541160.
  • Négyessy L, Vidnyánszky Z, Kuhn R, Knöpfel T, Görcs TJ, Hámori J. 1997. Light and electron microscopic demonstration of mGluR5 metabotropic glutamate receptor immunoreactive neuronal elements in the rat cerebellar cortex. J Comp Neurol 385: 641650.
  • Neki A, Oishi H, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. 1996. Metabotropic glutamate receptors mGluR2 and mGluR5 are expressed in two non-overlapping populations of Golgi cells in the rat cerebellum. Neuroscience 75: 815826.
  • Notenboom RG, Hampson DR, Jansen GH, van Rijen PC, van Veelen CW, van Nieuwenhuizen O, de Graan PN. 2006. Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain 129: 96107.
  • Oblak A, Gibbs TT, Blatt GJ. 2009. Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Res 2: 205219.
  • Oka A, Takashima S. 1999. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol 97: 275278.
  • Oostra BA, Willemsen R. 2009. FMR1: a gene with three faces. Biochem Biophys Acta 1790: 467477.
  • Palmen SJ, van Engeland H, Hof PR, Schmitz C. 2004. Neuropathological findings in autism. Brain 127: 25722583.
  • Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. 2001. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 7: 10581066.
  • Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57: 16181628.
  • Raol YH, Lynch DR, Brooks-Kayal AR. 2001. Role of excitatory amino acids in developmental epilepsies. Ment Retard Dev Disabil Res Rev 7: 254260.
  • Realmuto GM, Azeem MW. 2008. Autistic disorder. In: Fatemi SH, Clayton P, editors. The medical basis of psychiatry, 3rd ed. New York: Humana Press. p 355374.
  • Romano C, Miller JK, Hyrc K, Dikranian S, Mennerick S, Takeuchi Y, Goldberg MP, O'Malley KL. 2001. Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGluR5 dimerization. Mol Pharmacol 59: 4653.
  • Romano C, Van den Pol AN, O'Malley KL. 1996. Enhance early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA, splice variants, and regional distribution. J Comp Neurol 367: 403412.
  • Samaco RC, Hogart A, LaSalle JM. 2005. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14: 483492.
  • Sarto I, Wabnegger L, Dogl E, Sieghart W. 2002. Homologous sites of GABAA receptor α1, β3, γ2 subunits are important for assembly. Neuropharmacology 43: 482491.
  • Schwendt M, McGinty JF. 2007. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor 5 in rat striatum: relevance to amphetamine behavioral sensitization. J Pharmacol Exp Ther 323: 650657.
  • Scott JA, Schumann CM, Goodlin-Jones BL, Amaral DG. 2009. A comprehensive volumetric analysis of the cerebellum in children and adolescents with autism spectrum disorder. Autism Res 2: 246257.
  • Sheikh AM, Li X, Wen G, Taqeer D, Brown WT, Malik M. 2010. Cathespin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 165: 363370.
  • Steinlin M. 2008. Cerebellar disorders in childhood: cognitive problems. Cerebellum 7: 607610.
  • Tilleux S, Berger J, Hermans E. 2007. Induction of astrogliosis by activated microglia is associated with a down-regulation of metabotropic glutamate receptor 5. J Neuroimmunol 189: 2330.
  • Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 6781.
  • Wang H, Westin L, Nong Y, Birnbaum S, Bendor J, Brismar H, Nestler E, Aperia A, Flajolet M, Greengard P. 2009. Norbin in an endogenous regulator of metabotropic glutamate receptor 5 signaling. Science 326: 15541557.
  • Webb SJ, Sparks BF, Friedman SD, Shaw DW, Giedd J, Dawson G, Dager SR. 2009. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res 172: 6167.
  • Yip J, Soghomonian JJ, Blatt GJ. 2007. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathologica 113: 559568.